JPRN-UMIN000020615招募中未知
Effects of an Inhibitor of Sodium-glucose Cotransporter 2 for Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease (NAFLD). - SGLT2 Inhibitor for T2DM with NAFLD.
Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine.0 个研究点目标入组 20 人开始时间: 2016年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1: Diabetic ketoacidosis and hyperosmolar hyperglycemic state 2: Insulin dependent diabetes 3: Before and after surgery and severe trauma 4: Taking excessive alcohol 5: Severe renal failure or undergoing hemodialysis 6: Proliferative diabetic retinopathy 7: Obvious orthostatic hypotension 8: Patient who cannot be ruled out other liver disease including viral hepatitis, autoimmune hepatitis, a drug-induced hepatitis. 9: Severe hepatic dysfunction 10: Malignant neoplasm 11: Women who have a possibility of pregnancy or is pregnant 12: Allergy to SGLT2 inhibitors, having a recent history of taking SGLT2 inhibitors 13: Patient who is suspected type 1 diabetes and other diabetes
研究者
相似试验
已完成
不适用
Effect of Sodium-Glucose Cotransporter-2 inhibitor in patients with type 2 daibetes mellitusJPRN-UMIN000014168Jichi Medical University82
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
尚未招募
3 期
A clinical trial to study the effect of a drug,dapagliflozin in type 2 diabetic mellitus patient having diabetic macular edemaCTRI/2019/03/017915Postgraduate Institute of Medical Education and Research
进行中（未招募）
1 期
SOdium-glucose CO-transporter inhibition in patients with Type 2 Diabetes and Ischemic Heart FailurePatients with type 2 diabetes mellitus and heart failure of ischemic originEUCTR2015-005715-32-SEKarolinska Institutet Stockholm, Sweden60
已完成
不适用
Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018367Ise Red Cross Hospital Department of Metabolic Diseases30